Gene · 6518
Papers1,573
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 1,573
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Carbohydrate Storage and Supplementation Strategies for Peak Performance in Cross-Country Skiing. | Scand J Med Sci Sports | 2026 | 41755452 | PubTator, text mining | PubMed |
| Nutritional Management of Irritable Bowel Syndrome. | Nutrients | 2026 | 41754216 | PubTator, text mining | PubMed |
| The interplay of dietary sugar, chronic inflammation, and bladder cancer: mechanistic insights, evidence, and prevention strategies. | Front Immunol | 2026 | 41737225 | PubTator, text mining | PubMed |
| The impact of p53 mutation on tumor immune evasion: mechanistic insights and clinical implications. | Front Immunol | 2026 | 41727427 | PubTator, text mining | PubMed |
| Medium-chain fatty acids activate fructose metabolism via up-regulating GLUT5-KHK axis. | Biochem Biophys Res Commun | 2026 | 41619507 | PubTator, text mining | PubMed |
| Epigenetic and metabolic rewiring in metastatic pheochromocytomas and paragangliomas driven by SDHB mutations. | Commun Biol | 2026 | 41540233 | PubTator, text mining | PubMed |
| Fructose malabsorption induces dysbiosis and increases anxiety in male human and animal models. | Brain Behav Immun | 2026 | 41418890 | PubTator, text mining | PubMed |
| A mammalian, glutaminase-free asparaginase enhances venetoclax activity in preclinical AML models with chromosome 7 deletion. | Front Oncol | 2025 | 41743183 | PubTator, text mining | PubMed |
| Curcumin and bisdemethoxycurcumin inhibit glucose and enhance fructose absorption in differentiated Caco-2 cells, while dibenzoylmethane inhibits glucose absorption. | Food Res Int | 2025 | 41606929 | PubTator, text mining | PubMed |
| Fructose uptake by brown adipose tissue is independent of carbohydrate response element-binding protein and does not cause elevated de novo lipogenesis. | Acta Biochim Biophys Sin (Shanghai) | 2025 | 41408829 | PubTator, text mining | PubMed |
| Dysregulated Intestinal Nutrient Absorption in Obesity Is Associated with Altered Chromatin Accessibility. | Organoids | 2025 | 41394425 | PubTator, text mining | PubMed |
| Fructose Malabsorption, Gut Microbiota and Clinical Consequences: A Narrative Review of the Current Evidence. | Life (Basel) | 2025 | 41302144 | PubTator, text mining | PubMed |
| Epigenetic programs shaping lung metastasis in triple-negative breast cancer. | Res Sq | 2025 | 41282099 | PubTator, text mining | PubMed |
| KLC3 drives gastric cancer progression by stabilizing SLC2A5 to activate MAPK signaling and promote epithelial-mesenchymal transition. | BMC Cancer | 2025 | 41214559 | PubTator, text mining | PubMed |
| High-Fructose Corn Syrup on Inflammation and Cancer. | World J Oncol | 2025 | 41208845 | PubTator, text mining | PubMed |
| Role and mechanism of circ_001024 endogenous competition for miR-145-3p targeting to regulate GLUT5 in RCC. | BMC Cancer | 2025 | 41194024 | PubTator, text mining | PubMed |
| Effects of Maternal Nutrition and One-Carbon Metabolite Supplementation on Fetal Jejunal Morphology and Hexose Transporter Expression in Beef Cattle. | Vet Sci | 2025 | 41012809 | PubTator, text mining | PubMed |
| Fructose drives colorectal cancer progression by regulating crosstalk between cancer-associated fibroblasts and tumour cells. | Gut | 2025 | 40935617 | PubTator, text mining | PubMed |
| Review: microbial metabolites - a key to address gut inflammation and barrier dysfunction in the premature infant. | Gut Microbes | 2025 | 40887742 | PubTator, text mining | PubMed |
| Donor-dependent regulation of type II and X collagen deposition by early modulation of miR-335-5p and miR-1246 during chondrogenic commitment. | Stem Cell Res Ther | 2025 | 40877986 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6518/papers?page=2